EGFR and colorectal cancer: The study found that the potential targets of calycosin on colorectal cancer were ERα, ERβ, ATP-binding cassette subfamily G member 2, breast cancer type 1 susceptibility protein, CYP19A1, and epidermal growth factor receptor (EGFR) [22].